L 37/18
EN
Official Journal of the European Union
18.2.2022
(12)
Poland has notified to the Commission outbreaks of infection with RABV in several regions of the Voivodship Mazowieckie and Voivodship Świętokrzyskie, which are currently listed as disease-free status zones in Part I of Annex III to Implementing Regulation (EU) 2021/620.
Therefore, the affected regions should be deleted from that list and the entry for that Member State in that list should be amended accordingly.
(13)
For infection with RABV, Poland and Romania have submitted to the Commission applications to have their eradication programmes approved.
Following the assessment by the Commission, those applications have been shown to comply with the criteria laid down in Chapter 2 of Part II of Delegated Regulation (EU) 2020/689 for the approval of eradication programmes.
Therefore the Member States or zones thereof covered by those eradication programmes should be listed in Part II of Annex III to Implementing Regulation (EU) 2021/620, as having an approved eradication programme for infection with RABV.
(14)
For infection with BVD, Austria, Finland and Sweden have submitted to the Commission information demonstrating that the conditions for recognition of disease-free status from BVD laid down in Delegated Regulation (EU) 2020/689 are fulfilled for the whole of their territories.
In addition, Germany has submitted to the Commission information demonstrating that the conditions for recognition of disease-free status from BVD are fulfilled for certain zones of its territory.
Germany has also submitted to the Commission applications to have eradication programmes approved for other zones of its territory.
Following the assessment by the Commission, those applications have been shown to comply with the criteria laid down in Chapter 2 of Part II of Delegated Regulation (EU) 2020/689 for the granting of disease-free status or for approval of eradication programmes for BVD, respectively.
Therefore, those Member States or zones thereof should be listed accordingly in Annex VII to Implementing Regulation (EU) 2021/620, as having respectively disease-free status from BVD or an approved eradication programme for BVD.
(15)
Spain has notified to the Commission outbreaks of infection with BTV serotype 4 in the Autonomous Community of Castilla-La Mancha, which affected the regions of Peñarroya-Pueblonuevo, Hinojosa del Duque (Pedroches II), Pozoblanco (Pedroches I), Villanueva de Córdoba (Pedroches III), Montoro (Alto del Guadalquivir), Andújar and Linares in the Autonomous Community of Andalucia, The outbreaks have also affected the regions of Almadén, Almodóvar del Campo and Piedrabuena in the Autonomous Community of Castilla-La Mancha, as well as the Province of Badajoz and the regions of Coria, Valencia de Alcántara, Cáceres and Trujillo y Logrosán (Zorita) in the Autonomous Community of Extremadura.
Those affected regions, which are located in the Autonomous Community of Andalucia, in the Autonomous Community of Extremadura, and in the Autonomous Community of Castilla-La Mancha, respectively, are currently all listed as having disease-free status for infection with BTV, in Part I of Annex VIII to Implementing Regulation (EU) 2021/620.
The disease-free status of those regions for infection with BTV should be withdrawn, and the entry for Spain in that list should be amended accordingly.
(16)
In addition, Portugal has notified to the Commission outbreaks of infection with BTV serotype 4 in the Castelo Branco and Setubal districts.
Since Castelo Branco and Setubal districts, as part of Portugal, are located in the disease-free status areas listed in Part I of Annex VIII to Implementing Regulation (EU) 2021/620, their disease-free status for infection with BTV should be withdrawn, and the entry for Portugal in that list should be amended accordingly.
(17)
Furthermore, as regards infection with BTV, Spain has submitted to the Commission an application to have an optional eradication programme approved.
Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Chapter 2 of Part II of Delegated Regulation (EU) 2020/689.
Therefore the zones covered by that eradication programme should be listed in Part II of Annex VIII to Implementing Regulation (EU) 2021/620, as having an approved eradication programme for infection with BTV.
(18)
As regards the aquatic disease infectious haematopoietic necrosis (IHN), Denmark has informed the Commission that the conditions to maintain disease-free status for its whole territory are no longer met.
Denmark is listed in Part I of Annex XIII to Implementing Regulation (EU) 2021/620.
The entry for Denmark should therefore be deleted from that list.